, Tracking Stock Market Picks
Enter Symbol:
Impax Laboratories, Inc. (IPXL) [hlAlert]

up 246.22 %

Impax Laboratories, Inc. (IPXL) rated Overweight with price target $16 by Piper Jaffray

Posted on: Friday,  Dec 11, 2009  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Impax Laboratories, Inc. (NASDAQ: IPXL) on 12/11/2009, when the stock price was $12.70. Since
then, Impax Laboratories, Inc. has gained 246.22% as of 01/20/2016's recent price of $43.97.
If you would have followed this Piper Jaffray's recommendation on IPXL, you would have gained 246.22% of your investment in 2231 days.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company. The Company is focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals, utilizing its controlled-release and other in-house development and formulation expertise. In the generic pharmaceuticals market, the Company focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system (CNS), disorders. Its brand-name product portfolio consists of development-stage projects to which it is applying its formulation and development expertise to develop differentiated, modified, or controlled-release versions of marketed drug substances. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceutical Division (Impax Division).

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/11/2009 8:25 AM Buy
12.70 16.00
as of 12/31/2009
1 Week up  60.23 %
1 Month up  61.64 %
3 Months   
1 YTD up  61.64 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy